Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.
CONCLUSION: In patients with inflammatory rheumatic diseases, the elevated cardiovascular risk should be kept in mind and preventive measures should be initiated early. This subject should be further studied in controlled trials so that the treatment options for patients with cardiac involvement can be evaluated.
PMID: 28407841 [PubMed - in process]
Source: Deutsches Arzteblatt International - Category: Journals (General) Tags: Dtsch Arztebl Int Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Cardiology | Cardiovascular | Congestive Heart Failure | Endocarditis | General Medicine | Heart | Heart Failure | Heart Valve Disease | Heart Valves | Methotrexate | Myocarditis | Pericarditis | Primary Care | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Vasculitis